Circa 2012
Researchers have identified seven genetic markers linked with a woman’s breast size, according to a new study.
While it’s was known that breast size is in part heritable, the study is the first to find specific genetic factors that are associated with differences in breast size, the researchers said.
Circa 2017 face_with_colon_three
Study of more than 195,000 people finds 16 common genetic variants associated with muscle strength and gives insight into underlying biological mechanisms.
Circa 2020 Basically this means a magnetic transistor can have not only quantum properties but also it can have nearly infinite speeds for processing speeds. Which means we can have nanomachines with near infinite speeds eventually.
Abstract The discovery of spin superfluidity in antiferromagnetic superfluid 3He is a remarkable discovery associated with the name of Andrey Stanislavovich Borovik-Romanov. After 30 years, quantum effects in a magnon gas (such as the magnon Bose–Einstein condensate and spin superfluidity) have become quite topical. We consider analogies between spin superfluidity and superconductivity. The results of quantum calculations using a 53-bit programmable superconducting processor have been published quite recently[1]. These results demonstrate the advantage of using the quantum algorithm of calculations with this processor over the classical algorithm for some types of calculations. We consider the possibility of constructing an analogous (in many respecys) processor based on spin superfluidity.
Circa 2016 😗
Last month, Google’s AI division, DeepMind, announced that its computer had defeated Europe’s Go champion in five straight games. Go, a strategy game played on a 19×19 grid, is exponentially more difficult for a computer to master than chess—there are 20 possible moves to choose from at the start of a chess game compared to 361 moves in Go—and the announcement was lauded as another landmark moment in the evolution of artificial intelligence.
Or, at least, living neurons. His startup, Koniku, which just completed a stint at the biotech accelerator IndieBio, touts itself as “the first and only company on the planet building chips with biological neurons.” Rather than simply mimic brain function with chips, Agabi hopes to flip the script and borrow the actual material of human brains to create the chips.
Watch the Full Video at https://www.jove.com/v/55334/in-vivo-tracking-edema-developm…ideos-2022.
In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging — a 2 minute Preview of the Experimental Protocol.
A child born in Australia today is expected to live until the age of 84.3, giving the nation the third-highest life expectancy in the world behind Monaco and Japan. The increase is due to its early covid-19 containment and high-performing healthcare system.
Elon Musk has been touting Tesla’s FSD Beta v11 for some time now, and it’s finally here. He says it will be ready for wide rollout before the end of 2022.
Amazon unveils its newest warehouse robotic arm that utilizes artificial intelligence, which proves a terrifying possibility for Amazon warehouse workers to be easily replaced. John Iadarola and Jessica Burbank break it down on The Damage Report.
Amazon’s new robot should strike fear into its hundreds of thousands of warehouse workers — https://www.businessinsider.com/amazon-released-warehouse-ro…022-11
Continue reading “Amazon Robot UNVEILED, Warehouse Worker Panic Stirs” »
For more information on pancreatic cancer, please visit https://cle.clinic/3rvBj1a.
Pancreatic cancer accounts for about 3% of all cancers in the United States and about 7% of all cancer deaths. Because it’s hard to detect early, it’s important to recognize any symptoms that occur.
Find out what to look for and when you should talk to your provider with this helpful video from Cleveland Clinic.
A vaccine (DCVax-L), trialed at King’s College Hospital and other centers around the world, using patients’ immune cells to target brain cancer can extend survival by many months or, in some cases, years, the final unblinded results from a phase 3 clinical trial has shown. The final results were published on Thursday, November 17 in JAMA Oncology.
This is the first time in 17 years that such significant outcomes have been achieved in a phase 3 trial for a systemic treatment in newly diagnosed glioblastoma, and the first time in 27 years that any treatment has been shown to extend survival in recurrent glioblastoma.
The vaccine is created for each patient individually by isolating specific immune cells, known as dendritic cells, from their blood. These cells are then primed with biomarkers from a sample of the patient’s tumor. When the vaccine containing the cells is injected back into the patient, it shares that information so that the body’s entire immune system recognizes and attacks the target.
